UBS Maintains Buy on Abbott Laboratories, Raises Price Target to $146

Benzinga · 10/17 15:50
UBS analyst Danielle Antalffy maintains Abbott Laboratories (NYSE:ABT) with a Buy and raises the price target from $143 to $146.